MC
Cenerenti, Mara
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer | Science advances |  | 2025 | 92 | 212 | ||
| Unraveling cytotoxic tumor-specific CD4 T cells for advanced clinical applications |  | 2024 | 250 | 0 | |||
| Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | Cell | | 2024 | 994 | 349 | ||
| Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability | Frontiers in immunology | | 2023 | 119 | 85 | ||
| Dendritic cells direct circadian anti-tumour immune responses | Nature | | 2023 | 799 | 221 | ||
| The era of cytotoxic CD4 T cells | Frontiers in immunology | | 2022 | 218 | 266 | ||
| Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer | Science Advances | | 2021 | 498 | 406 | ||
| Impact of immunotherapy on CD4 T cell phenotypes and function in cancer | Vaccines | | 2021 | 262 | 223 |
